medigraphic.com

2014, Number 2

<< Back Next >>

Enf Infec Microbiol 2014; 34 (2)

Ozonated oils in the treatment of infectious diseases

Curtiellas PV

Language: Spanish
References: 30
Page: 64-68
PDF size: 162.36 Kb.


ABSTRACT

The use of ozonized oils has been effective in the treatment of numerous infectious diseases. However, many aspects concerned to the interaction of these agents with microorganisms and human cells remain still unknown. This paper reviews major key points on the antimicrobial activity of ozonated oils, and their applications in this field, which have been supported by preclinical and clinical trials. Interactions between ozonated oils and microorganisms are analyzed and mechanisms to justify their action and selective toxicity are proposed. New applications under study and potentialities that remain to be exploited for use in the control of infectious disease are also commented.


REFERENCES

  1. Falcón L, Menéndez S, Simón R y col. “Aceite ozonizado en dermatología. Experiencia de 9 años”. Rev CENIC Ciencias Biol 1998; 29(3):192-195.

  2. Travagli V, Zanardi I, Bocci V. “Topical applications of ozone and ozonated sunflower oils as anti-infective agents: an insight into the patient claims”. Recent Pat Antiinfect Drug Discov 2009; 4(2):130-142.

  3. Menéndez S, Falcón L, Simón DR y col. “Efficacy of ozonized sunflower oil in the treatment of tinea pedis”. Mycosis 2002; 45:329-332.

  4. Amaroto M, Fernández M, Rodríguez Y y col. “Eficacia del aceite ozonizado OLEOZON® en el tratamiento de la giardiasis. Ensayo clínico fase III, aleatorizado, abierto y controlado”. Rev Cub Farm 2002; 36(2):173- 175.

  5. Martínez GL, Re L, Pérez-Davison G y col. “Las aplicaciones médicas de los aceites ozonizados, actualización”. Rev Esp Ozonoterapia 2012; 2(1):121-139. Sechi LA, Lezcano I, Espino M y col. “Antibacterial activity of ozonized Sunflower oil (Oleozon)”. J Appl microbiol 2001; 90:279-284.

  6. Lezcano I, Núñez N, Gutiérrez M y col. “Actividad in vitro del aceite de girasol ozonizado frente a diferentes especies bacterianas”. Rev CENIC Ciencias Biol 1996; 27(1):46-49.

  7. Ledea O, Curtiellas V, Molerio J y col. “Evidencias del mecanismo oxidante en la actividad antibacteriana del aceite de girasol ozonizado”. Rev CENIC Ciencias Quim 2010; 41:1-13.

  8. Thomson P, Anticevic S, Rodríguez H y col. “Actividad antifúngica y perfil de seguridad del producto natural derivado del aceite de maravilla ozonizado (AMO3) en dermatofitos”. Rev Chil Infect 2011; 28(6):512-519.

  9. Orrenius S, Gogvadze A, Zhivotovski B. “Mitochondrial oxidative estrés: implications for cell death”. Ann Rev Pharmacol Toxicol 2007; 47:143-183.

  10. Sies H, Menck CF. “Singlet oxygen induced DNA damage”. Mutat Res 1992; 275:367-375.

  11. Cabiscol E, Tamarit J, Ros J. “Oxidative stress in bacteria and protein damage by reactive oxygen species”. Internatl Microbiol 2000; 3:3-8.

  12. Chen JJ, Yu BP. “Alterations in mitochondrial membrane fluidity by lipid peroxidation products”. Free Rad Biol med 1994; 17(5):411-418.

  13. Curtiellas V, Ledea O, Rodríguez S y col. “El OLEOZON ® sobre la viabilidad, la permeabilidad celular y la ultra estructura de Staphylococcus aureus”. Rev CENIC Ciencias Biol 2008; 39(2):128-131.

  14. Kohanski MA, Dwyer DJ, Hayete B y col. “A common mechanism of cellular death induced by bactericidal antibiotics”. Cell 2007; 130(5):797-810.

  15. Cristophorou MA, Ringhausen I, Finch AJ y col. “The pathological p53-mediated response to DNA damage is distinct from p53 mediated tumor suppression”. Nature 2006; 443:214-217.

  16. Lobanov AV, D.L. Hatfield DL, Gladyshev VN. “Eukaryotic selenoproteins and selenoproteomes”. Biochim Biophys Acta 2009; 1790:1424-1428.

  17. Kim HY, Fomenko DE, Yoon YE y col. “Catalytic advantages provided by selenocysteine in methionine S-sulfoxide reductases”. Biochemistry 2006; 45:13697- 13704.

  18. Gladyshev VN, “Identity, evolution and function of selenoproteins and selenoprotein genes” en Hatfield DL, Selenium: its molecular biology and role in human health, Norwell, MA, 2001:99-114.

  19. Kryukov GV, Castellano S, Novoselov SV y col. “Characterization of mammalian selenoproteomes”. Science 2003; 300:1439-1443.

  20. Flohé L, “Glutathione peroxidase” en Liu J, Luo G, Mu Y, Selenoproteins and mimics, NY, 2011:1-25.

  21. Halliwell B. “Antioxidant defence mechanisms: from the beginning to the end (of the beginning)”. Free Radic Res 1999; 31(4):261-272.

  22. Levine RL, Mosoni L, Berlett BS y col. “Methionine residues as endogenous antioxidants in proteins”. Proc Nat Acad Sci 1996; 93:15036-15040.

  23. Chae HZ, Rhee SG. “A thiol specific antioxidant and sequence homology to various proteins of unknown function”. Biofactors; 1994; 4:177-180.

  24. Hofmann B, Hecht HJ, Flohé, L. “Peroxiredoxins”. Biol Chem 2002; 383:177-180.

  25. Budanov AV, Sablina AA, Feinstein E y col. “Regeneration of peroxiredoxins by p53-Regulated sestrins, homologs of bacterial AhpD”. Science 2004; 300:596- 600.

  26. Wood ZA, Poole L, Karplus PA. “Peroxiredoxins evolution and the regulation of hydrogen peroxide signaling”. Science 2003; 300:650-653.

  27. Georgiu G, Masip L. “Biochemistry. An overoxidation journey with a return ticket”. Science 2003; 304:592- 594.

  28. Bowie A, O´Neill LA. “Studies into the mechanism of NF Kappa B activation by IL 1, TNF and H2O2 in primary and transformed endothelial cells”. Biochem Soc Trans 1997; 25(1):125S.

  29. Díaz MF. “Usos y propiedades de los aceites vegetales ozonizados. La experiencia cubana”. Rev CENIC Ciencias Biol 2010; 27(1):46-49.

  30. Copello N, Menéndez S, Schwartz A. “Efectos del aceite ozonizado en la conjuntivitis hemorrágica epidémica”. Rev Esp Ozonoterapia 2012; 2(1): 107-120.




2020     |     www.medigraphic.com